WHOCC
Postal address:
WHO Collaborating Centre for Drug Statistics Methodology
Norwegian Institute of Public Health
P.O.Box 4404 Nydalen
0403 Oslo
Norway

Visiting/delivery address:
Marcus Thranes gate 6
0473 Oslo
Norway

Tel:  +47 21 07 81 60
E-mail:
 
Copyright/Disclaimer

List of DDDs for 3 years revision

The DDDs, which will be reviewed at the March 2017 meeting (3 year revision) are listed below.  See also Guidelines: Part III; D Principles for reviewing and changing DDD and Part V; D Requests for changes to DDDs. The deadline for applications for alterations and comments is 1 February 2017.  

 

ATC codeATC level name (INN/generic name)DDDUnitAdm.route
A01AD02benzydamide9mgO
A02BC06dexlansoprazole30mgO
A04AA05palonosetron0.5mgO
A06AX04linaclotide0.29mgO
C02KX04macitentan10mgO
G04BE10avanafil0.1gO
J05AX12dolutegravir50mgO
J05AX13umifenovir0.8gO
J05AX15sofosbuvir0.4gO
L02BB04enzalutamide0.16gO
L04AX06pomalidomide3mgO
N05AE05lurasidone60mgO
N05BX04fabomotizole30mgO
N06AX26vortioxetine10mgO
N07BB05nalmefene18mgO
N07XX09dimethyl fumarate0.48gO
R06AX29bilastine20mgO
A10BX10lixisenatide20mcgP
B02BD11catridecacog2.5TUP
C01EB21regadenoson0.4mgP
J01CF06 nafcillin3gP
L03AA14lipegfilgrastim0.3mgP
L03AB14cepeginterferon alfa-2b17mcgP
L04AA34alemtuzumab0.13mgP
M04AX02pegloticase0.57mgP
A04AA02granisetron3.1mgTD

Last updated: 2016-12-20